
Development of a plasminogen activator inhibitor (PAI-1) assay and comparison of plasma PAI-1 activity in hyperlipidemic/dyslipidemic dogs with either hyperadrenocorticism or diabetes mellitus, and healthy dogs
Keywords: فیبرینولیز; Cholesterol; Triglycerides; Endocrinopathy; Fibrinolysis; Thrombosis;